Who owns AYTU BIOPHARMA INC?
- Ticker: AYTU
- CUSIP Number: 054754858
Tip: Access positions for across all investors
Analyze quarterly positions in Aytu Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Aytu Biopharma stock
Who bought or sold AYTU BIOPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Nantahala Capital Management | 1.1M | $2.8M | 0% | Dec 2025 |
|
| Stonepine Capital Management | 814k | $2.1M | -9% | Dec 2025 |
|
| AWM Investment Company | 620k | $1.6M | 0% | Dec 2025 |
|
| Vanguard Group | 279k | $724k | 0% | Dec 2025 |
|
| Diadema Partners | 273k | $513k | 100% | Sep 2025 |
|
| Renaissance Technologies | 90k | $233k | -6% | Dec 2025 |
|
| Geode Capital Management | 74k | $193k | 4% | Dec 2025 |
|
| Two Sigma Investments | 69k | $129k | 96% | Sep 2025 |
|
| Persistent Asset Partners | 63k | $117k | 100% | Sep 2025 |
|
| Two Sigma Advisers | 40k | $75k | 100% | Sep 2025 |
|
| Dimensional Fund Advisors | 35k | $92k | 14% | Dec 2025 |
|
| FNY Investment Advisers | 32k | $82k | 24208% | Dec 2025 |
|
| DRW Holdings | 29k | $76k | 100% | Dec 2025 |
|
| XTX Topco | 26k | $67k | 100% | Dec 2025 |
|
| Bellevue Asset Management | 25k | $65k | 100% | Dec 2025 |
|
| BlackRock | 23k | $43k | 0% | Sep 2025 |
|
| Sentinus | 20k | $52k | 100% | Dec 2025 |
|
| Northern Trust | 19k | $50k | 100% | Dec 2025 |
|
| Acadian Asset Management | 10k | $26k | 0% | Dec 2025 |
|
| MAI Wealth Advisors | 3.6k | $9.3k | 0% | Dec 2025 |
|
| UBS Group | 3.0k | $7.9k | -3% | Dec 2025 |
|
| Tower Research Capital | 1.7k | $4.5k | -60% | Dec 2025 |
|
| Advisor Group Holdings | 460.00 | $1.2k | 1% | Dec 2025 |
|
| Wells Fargo & Company | 127.00 | $328.079100 | 0% | Dec 2025 |
|
| Atlantic Trust | 83.00 | $215.999200 | 0% | Dec 2025 |
|
| SBI Securities | 62.00 | $117.000200 | -71% | Sep 2025 |
|
| Group One Trading | 37.00 | $96.000200 | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 23.00 | $60.000100 | 0% | Dec 2025 |
|
| Goss Wealth Management | 21.00 | $54.999000 | 0% | Dec 2025 |
|
| FMR | 5.00 | $9.000000 | 100% | Sep 2025 |
|
| Vision Financial Markets | 2.00 | $6.000000 | 0% | Dec 2025 |
|
| TSFG | 1.00 | $0 | 0% | Dec 2025 |
|
| Jones Financial Companies, L.L | 1.00 | $2.000000 | 0% | Sep 2025 |
|
Who sold out of Aytu Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jaffetilchin Investment Partners | Sep 2025 | 17k | $33k |
| Raymond James Financial | Jun 2025 | 55.00 | $120.230000 |
| Barclays | Sep 2025 | 1.00 | $2.000000 |